Skip to content

Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction

Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06788418
Enrollment
1000
Registered
2025-01-23
Start date
2025-01-20
Completion date
2025-12-31
Last updated
2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

myopia, Small Incision Lenticule Extraction, Implantable Collamer Lens, Wavelight Plus Alcon system, vision

Brief summary

Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.

Interventions

PROCEDUREWavelight Plus Alcon system

Wavelight Plus Alcon system guided surgery for myopia

PROCEDURESMILE

Small Incision Lenticule Extraction surgery for myopia

PROCEDUREICL

Implantable Collamer Lens surgery for myopia

Sponsors

High Myopia Control Alliance (HIMALAYA)
CollaboratorUNKNOWN
Beijing New Vision Eye Hospital
CollaboratorUNKNOWN
Shanghai Parkway Hospital
CollaboratorUNKNOWN
Beijing Visionly Plus Eye Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-40 years * Spherical equivalent of -1.00 to -10.00 D * Stable refraction for at least 12 months * Informed consent provided

Exclusion criteria

* Other ocular pathologies * Previous refractive surgery * Pregnancy or nursing * Autoimmune or connective tissue disorders

Design outcomes

Primary

MeasureTime frameDescription
Vision at 12 months post-surgeryFrom the day of surgery through to the 12-month post-operative follow-upUncorrected distance vision (UDVA) at 12 months post-surgery

Secondary

MeasureTime frameDescription
Change in spherical equivalent at 12 months post-surgeryFrom the day of surgery through to the 12-month post-operative follow-upChange of the spherical equivalent at 12 months post-surgery

Countries

China

Contacts

Primary ContactPeng ZHOU, M.D.
drzhoupeng@gmail.com+86-18801871108

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026